Detalhe da pesquisa
1.
Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes.
Am J Respir Crit Care Med
; 206(5): 545-553, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35549845
2.
Feno differentiates epithelial gene expression clusters: Exploratory analysis from the MESOS randomized controlled trial.
J Allergy Clin Immunol
; 150(4): 830-840, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35537502
3.
Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation.
Allergy
; 77(11): 3362-3376, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35778780
4.
Multi-omics links IL-6 trans-signalling with neutrophil extracellular trap formation and Haemophilus infection in COPD.
Eur Respir J
; 58(4)2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33766947
5.
Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline.
Eur Respir J
; 55(1)2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558662
6.
CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma.
Respir Res
; 21(1): 265, 2020 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33050900
7.
Sputum microbiomic clustering in asthma and chronic obstructive pulmonary disease reveals a Haemophilus-predominant subgroup.
Allergy
; 75(4): 808-817, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31556120
8.
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions.
Eur Respir J
; 54(3)2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31467120
9.
Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.
J Allergy Clin Immunol
; 141(6): 2027-2036.e12, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29709671
10.
Letter from the UK.
Respirology
; 25(12): 1323-1324, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33078495
11.
Computational modelling prediction and clinical validation of impact of benralizumab on airway smooth muscle mass in asthma.
Eur Respir J
; 54(5)2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31391226
12.
Mepolizumab does not alter the blood basophil count in severe asthma.
Allergy
; 74(12): 2488-2490, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31106444
13.
Big asthma data: getting bigger and more beautiful?
Thorax
; 73(4): 311-312, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29288213
14.
Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe Asthma.
NEJM Evid
; 2(10): EVIDoa2300135, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320181
15.
Novel Therapeutic Strategies in Asthma-Chronic Obstructive Pulmonary Disease Overlap.
Immunol Allergy Clin North Am
; 42(3): 671-690, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35965053
16.
Corticosteroid Responsiveness Following Mepolizumab in Severe Eosinophilic Asthma-A Randomized, Placebo-Controlled Crossover Trial (MAPLE).
J Allergy Clin Immunol Pract
; 10(11): 2925-2934.e12, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35863669
17.
The value of healthcare worker support strategies to enhance wellbeing and optimise patient care.
Future Healthc J
; 8(1): e60-e66, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33791478
18.
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial.
Lancet Respir Med
; 9(11): 1299-1312, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34256031
19.
The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.
Lancet Respir Med
; 9(10): 1174-1184, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33971168
20.
Cough and Eosinophilia.
J Allergy Clin Immunol Pract
; 7(6): 1740-1747, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31279462